Apolipoprotein E, Aβ-amyloid, and the molecular pathology of Alzheimer's disease: Therapeutic implications

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 42-49

  Kaplitt, Michael ^b   Gouras, Gunnar K ^b   Makimura, Hideo ^b   Jovanovic, Jasmina ^b   Sweeney, David ^b   Greengard, Paul ^b   Relkin, Norman R ^b   Gandy, Samuel ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; CONFERENCE PAPER; EXTRACELLULAR SPACE; GENETIC LINKAGE; HUMAN; MOLECULAR BIOLOGY; NERVE CELL PLASTICITY; ONSET AGE; PATHOLOGY; PROTEIN EXPRESSION;

EID: 0030481373     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32597.x     Document Type: Conference Paper

References (64)

1. BRESLOW, J. L. 1985. Human apolipoprotein molecular biology & genetic variation. Ann. Rev. Biochem. 54: 699-727.
2. PLUMP, A. S., J. D. SMITH, T. HAYEK, K. AALTO-SETALA, A. WALSH, J. G. VERSTUYFT, E. M. RUBIN & J. L. BRESLOW. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
3. ELSHOURBAGY, N. A., W. S. LIAO, R. W. MAHLEY & J. M. TAYLOR. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA 82: 203-207.
4. BOYLES, J. K., R. E. PITAS, E. WILSON, R. W. MAHLEY & J. M. TAYLOR. 1985. ApoE associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Inv. 76: 1501-1513.
5. STRITTMATTER, W. J., A. M. SAUNDERS, D. SCHMECHEL, M. PERICAK-VANCE, J. ENGHILD, G. S. SALVESEN & A. D. ROSES. 1993. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
6. PERICAK-VANCE, M. A., J. L. BEBOUT, P. C. GASKELL, JR., L. YAMAOKA, W. Y. HUNG, M. J. ALBERTS, A. P. WALKER, R. J. BARTLETT, C. A. HANES, K. A. WELSH, N. L. EARL, A. HEYMAN, C. M. CLARK & A. D. ROSES. 1991. Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48: 1034-1050.
7. NAMBA, Y., M. TOMONAGA, H. KAWASAKI, E. OTOMO & K. IKEDA. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541: 163-166.
8. WISNIEWSKI, T. & B. FRANGIONE. 1992. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135: 235-238.
9. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST. GEORGE-HYSLOP, M. A. PERICAK-VANCE, S. H. JOOS, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACHLAN, M. J. ALBERTS, C. HULETTE, B. CRAIN, D. GOLDGABER & A. D. ROSES. 1993. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
10. MAYEUX, R., Y. STERN, R. OTTMAN, T. K. TATEMICHI, M. X. TANG, G. MAESTRE, C. NGAI, B. TYCKO & H. GINSBERG. 1993. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34: 752-754.
11. MARTINS, R. N., R. CLARNETTE, C. FISHER, G. A. BROE, W. S. BROOKS, P. MONTGOMERY & S. E. GANDY. 1995. ApoE genotypes in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport 6: 1513-1516.
12. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
13. REBECK, G. W., J. S. REITER, D. K. STRICKLAND & B. T. HYMAN. 1993. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11: 575-580.
14. SCHMECHEL, D. E., A. M. SAUNDERS, W. J. STRITTMATTER, B. J. CRAIN, C. M. HULETTE, S. H. JOO, M. A. PERICAK-VANCE, D. GOLDGABER & A. D. ROSES. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 9649-9653.
15. BERR, C., J. J. HAUW, P. DELAERE, C. DUYCKAERTS & P. AMOUYEL. 1994. Apolipoprotein E allele ∈4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci. Lett. 178: 221-224.
16. SANAN, D., K. WEISGRABER, S. RUSSELL, R. MAHLEY, D. HUANG, A. SAUNDERS, D. SCHMECHEL, T. WISNIEWSKI, B. FRANGIONE, A. ROSES & W. STRITTMATTER. 1994. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils: Isoform ApoE4 associates more efficiently than ApoE3. J. Clin. Invest. 94: 860-869.
17. MA, J., A. YEE, H. B. BREWER, JR., S. DAS & H. POTTER. 1994. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372: 92-94.
18. WISNIEWSKI, T., E. M. CASTANO, A. GOLABEK, T. VOGEL & B. FRANGIONE. 1994. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145: 1030-1035.
19. STRITTMATTER, W. J., K. H. WEISGRABER, D. Y. HUANG, L. M. DONG, G. S. SALVESEN, M. PERICAK-VANCE, D. SCHMECHEL, A. M. SAUNDERS, D. GOLDGABER & A. D. ROSES. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102.
20. LADU M., M. FALDUTO, A. MANELLI, C. REARDON, G. GETZ & D. FRAIL. 1994. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269: 23403-23406.
21. ZHOU, Z., J. SMITH, J. BRESLOW, P. GREENGARD & S. GANDY. 1996. Alzheimer amyloid-β peptide forms denaturant-resistant complex with E3 but not ∈4 isoform of native apolipoprotein E. Mol. Med. 2: 175-180.
22. GLENNER, G. G. & C. W. WONG. 1988. Alzheimer's disease: Initial report of purification and characteristics of novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 122: 885-890.
23. KANG, J., H. G. LEMAIRE, A. UNTERBECK, J. M. SALBAUM, C. L. MASTERS, K. H. GRZESCHIK, G. H. MULTHAUP, K. BEYREUTHER & B. MULLER-HILL. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
24. PONTE, P., P. GONZALES-DEWHITT, J. SCHILLING, J. MILLER, D. HSU, B. GREENBERG, K. DAVIS, W. WALLACE, I. LIEBERBURG, F. FULLER & B. A. CORDELL. 1988. New A4 amyloid contains a domain homologous to protease inhibitors. Nature 331: 525-527.
25. HARDY, J. 1993. Genetic mistakes point the way for Alzheimer's disease. J. NIH Res. 5: 46-49.
26. MULLAN, M., F. CRAWFORD, K. AXELMAN, H. HOULDEN, L. LILIUS, B. WINBLAD & L. LANNFELT. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1: 345-347.
27. CITRON, M., T. OLTERSDORF, C. HAASS, L. MCCONLOGUE, A. Y. HUNG, P. SEUBERT, C. VIGO-PELFREY, I. LIEBERBURG & D. J. SELKOE. 1992. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease causes increased β-protein production. Nature 360: 672-674.
28. CAI, X.-D., T. E. GOLDE & S. G. YOUNKIN. 1993. Release of excess amyloid β protein from mutant amyloid β protein precursor. Science 259: 514-516.
29. HAASS, C., A. Y. HUNG, D. J. SELKOE & D. B. TEPLOW. 1994. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269: 17741-17748.
30. WISNIEWSKI, T., J. GHISO & B. FRANGIONE. 1991. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179: 1247-1254.
31. 717) mutants. Science 264: 1336-1340.
32. KOO, E. H., S. S. SISODIA, L. C. CORK, A. UNTERBECK, R. M. BAYNEY & D. L. PRICE. 1990. Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates. Neuron 4: 97-104.
33. GANDY, S. E. & P. GREENGARD. 1992. Amyloidogenesis in Alzheimer disease: Some possible therapeutic opportunities. Trends Pharmacol. Sci. 13: 108-113.
34. GANDY, S. & P. GREENGARD. 1994. Processing of Aβ-amyloid precursor protein: Cell biology, regulation, and role in Alzheimer disease. Int. Rev. Neurobiol. 36: 29-50.
35. GANDY, S., C. CAPORASO, J. BUXBAUM, B. FRANGIONE & P. GREENGARD. 1994. APP processing, Aβ amyloidogenesis, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 15: 253-256.
36. WEIDEMANN, A., G. KONIG, D. BUNKE, P. FISCHER. J. M. SALBAUM, C. L. MASTERS & K. BEYREUTHER. 1989. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57: 115-126.
37. SISODIA, S. S., E. H. KOO, K. BEYREUTHER, A. UNTERBECK & D. L. PRICE. 1990. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
38. ESCH, F. S., P. S. KEIM, E. C. BEATTIE, R. W. BLACKER, A. R. CULWELL, T. OLTERSDORF, D. MCCLURE & P. J. WARD. 1990. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248: 1122-1124.
39. RAMABHADRAN, T. V., S. E. GANDY, J. GHISO, A. CZERNIK, D. FERRIS, R. BHASIN, D. GOLDGABER, B. FRANGIONE & P. GREENGARD. 1993. Proteolytic processing of human amyloid β protein precursor in insect cells: Major carboxyl terminal fragment is identical to its human counterpart. J. Biol. Chem. 268: 2009-2012.
40. NORDSTEDT, C., G. L. CAPORASO, J. THYBERG, S. E. GANDY & P. GREENGARD. 1993. Identification of the Alzheimer β/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J. Biol. Chem. 268: 608-612.
41. GOLDE, T., S. ESTUS, L. YOUNKIN, D. SELKOE & S. YOUNKIN. 1992. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255: 728-730.
42. HAASS, C., E. H. KOO, A. MELLON, A. Y. HUNG & D. J. SELKOE. 1992. Targeting of cell-surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357: 500-503.
43. CAPORASO, G. L., S. E. GANDY, J. D. BUXBAUM & P. GREENGARD. 1992. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89: 2252-2256.
44. SEUBERT, P., T. OLTERSDORF, M. G. LEE, R. BARBOUR, C. BLOMQUIST, D. L. DAVIS. K. BRYANT, D. GALASKO, L. J. THAL, L. FRITZ, I. LIEBERBURG & D. SCHENK. 1993. Secretion of β-amyloid precursor protein cleaved at the amino-terminus of the β-amyloid peptide. Nature 361: 260-263.
45. NORDSTEDT, C., S. GANDY, I. ALAFUZOFF, G. CAPORASO, K. IVERFELDT, J. GREBB, B. WINBLAD & P. GREENGARD. ALZHEIMER β/A4-amyloid precursor protein in human brain: Aging-associated increases in holoprotein and in a proteolytic fragment. 1991. Proc. Natl. Acad. Sci. USA 88: 8910-8914.
46. GANDY, S. E., R. BHASIN, T. V. RAMABHADRAN, E. H. KOO, D. L. PRICE, D. GOLDGABER & P. GREENGARD. 1992. Alzheimer β/A4 amyloid precursor protein: Evidence for putative amyloidogenic fragment. J. Neurochem. 58: 383-386.
47. ESTUS, S., T. GOLDE, T. KUNISHITA, D. BLADES, D. LOWERY, M. EISEN, M. USIAK, X. QU, T. TABIRA, B. GREENBERG & S. YOUNKIN. 1992. Potentially amyloidogenic C-terminal derivatives of amyloid protein precursor. Science 255: 726-728.
48. TAMAOKA, A., R. KALARIA, I. LIEBERBURG & D. SELKOE. 1992. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc. Natl. Acad. Sci. USA 89: 1345-1349.
49. KNOPS, J., I. LIEBERBURG & S. SINHA. 1992. Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells: Identification of a novel, 22-kDa, β-peptide containing intermediate. J. Biol. Chem. 267: 16022-16024.
50. HAASS, C., M. G. SCHLOSSMACHER, A. Y. HUNG, C. VIGO-PELFREY, A. MELLON, B. C. OSTASZEWSKI, I. LIEBERBURG, E. H. KOO, D. SCHENK, D. TEPLOW & D. J. SELKOE. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
51. SEUBERT, P., C. VIGO-PELFREY, F. ESCH, M. LEE, H. DOVEY, D. DAVIS, S. SINHA, M. SCHLOSSMACHER, J. WHALEY, C. SWINDLEHURST, R. MCCORMACK, R. WOLFERT, D. SELKOE, I. LIEBERBURG & D. SCHENK. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-327.
52. SHOJI, M., T. E. GOLDE, J. GHISO, T. T. CHEUNG, S. ESTUS, L. M. SHAFFER, X. CAI, D. M. MCKAY, R. TINTNER, B. FRANGIONE & S. G. YOUNKIN. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258: 126-129.
53. SIMMONS, L., P. MAY, K. TOMASELLI, R. RYDEL, K. FUSON, E. BRIGHAM, S. WRIGHT, I. LIEBKRBURG, G. BECKER, D. BREMS & W. LI. 1994. Secondary structure of amyloid β-peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45: 373-379.
54. WISNIEWSKI, T., J. GHISO & B. FRANGIONE. 1994. Alzheimer's disease and soluble Aβ. Neurobiol. Aging 15: 143-152.
55. IGNATIUS, M. J., P. J. GEBICKE-HARTER, J. H. P. SKENE, J. W. SCHILLING, K. H. WEISGRABER, R. W. MAHLEY & E. M. SHOOTER. 1986. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA 83: 1125-1129.
56. STRITTMATTER, W. J., K. H. WEISGRABER, M. GOEDERT, A. M. SAUNDERS, D. HUANG, E. H. CORDER, L.-M. DONG, R. JAKES, M. J. ALBERTS, J. R. GILBERT, S.-H. HAN, C. HULETTE, G. EINSTEIN, D. E. SCHMECHEL, M. A. PERICAK-VANCE & A. D. ROSES. 1994. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer brain as a function of apolipoprotein E genotype. Exp. Neurol. 125: 163-171.
57. RALL, S. C., K. H. WEISGRABER & R. W. MAHLEY. 1986. Isolation and characterization of apolipoprotein E. Methods Enzymol. 128: 273-287.
58. SCHACHTER, F., L. FAURE-DELANEF, F. GUENOT, H. ROUGER, P. FROGUEL, L. LESUEURGINOT & D. COHEN. 1994. Genetic associations with human longevity at the APOE and ACE loci. Natl. Genet. 6: 29-32.
59. CORDER, E. H., A. M. SAUNDERS, N. J. RISCH, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, J. B. RIMMLER, P. A. LOCKE, P. M. CONNEALLY, K. E. SCHMADER, G. W. SMALL, A. D. ROSES, J. L. HAINES, M. A. PERICAK-VANCE. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7: 180-184.
60. BENJAMIN, R., A. LEAKE, F. MCARTHUR, P. INCE, J. CANDY, J. EDWARDSON, C. MORRIS & E. BJERTNESS. 1994. Protective effect of apoE ∈2 in Alzheimer's disease. Lancet 344: 473.
61. CHARTIER-HARLIN, M.-C., M. PARFITT, S. LEORAIN, J. PEREZ-TUR, T. BROUSSEAU, A. EVANS, C. BERR, O. VIDAL, P. ROQUES, V. GOURLET, J.-C. FRUCHART, A. DELACOURTE, M. ROSSOR & P. AMOUYEL. 1994. Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3: 569-574.
62. TALBOT, C., C. LENDON, N. CRADDOCK, S. SHEARS, J. MORRIS & A. GOATE. 1994. Protection against Alzheimer's disease with apoE ∈2. Lancet 343: 1432-1433.
63. WEST, H., G. REBECK & B. HYMAN. Frequency of the apolipoprotein E ∈2 allele is diminished in sporadic Alzheimer disease. 1994. Neurosci. Lett. 175: 46-48.
64. KAPLITT, M. G., J. SMITH, F. FERRARI, R. J. SAMULSKI, D. W. PFAFF, M. J. DURING, S. GANDY & J. BRESLOW. 1995. Expression of human apolipoprotein E in rodent brain via an adeno-associated virus vector. Soc. Neurosci. Abstr. 21: 1008.